A Clearer Strategy for Responding to the Ebola Bundibugyo Outbreak Is Needed

The ongoing Ebola virus disease outbreak caused by Orthoebolavirus bundibugyoense (BDBV) in the Democratic Republic of the Congo highlights persistent gaps in global outbreak preparedness. Despite decades of experience with Ebola, delayed detection, limited access to care, insecurity, community mistrust, and fragmented response systems continue to hinder effective control and reduce survival. While non-pharmaceutical interventions remain essential, potentially effective medical countermeasures should be considered earlier. Existing vaccines and therapeutics developed against Ebola Zaire, although not licensed for BDBV, could be evaluated through carefully governed investigational or compassionate use alongside rigorous research. Effective response also requires strengthened surveillance, decentralized care, community engagement, and meaningful leadership by local scientists and healthcare professionals. This outbreak underscores the need for an adaptive, locally led, and internationally supported strategy that simultaneously saves lives and generates evidence.